Do you know people who work with animals, or in humid environments?
They may be at risk of contracting leptospirosis.
Leptospirosis, commonly called “Weil’s disease”, is a misunderstood bacterial disease transmitted to humans by some mammals.
The bacteria, called “Leptospira”, are primarily stored in the kidneys of contaminated animals, before passing into their urine. The animal’s coat and surrounding environment then become contaminated. Rodents and rats, in particular, are carriers of the most severe, sometimes fatal, form: Icterohemorrhagic leptospirosis(1).
The icterohaemorrhagiae serogroup is often the culprit behind cases of human leptospirosis, and is often the cause of the most serious cases worldwide.
In metropolitan France, for example, icterohemorrhagic leptospirosis accounts for a third of identified cases and, in particular, two thirds of serious cases requiring hospitalization(2).
In the United Kingdom, icterohemorrhagic leptospirosis accounts for approximately half of identified cases(3), and two thirds of identified cases in the Netherlands(4). Elsewhere in the world, Icterohaemorrhagiae accounts for two thirds of the cases in Réunion, for example, and half of the cases in French Polynesia(5,6).
LEPTOSPIROSIS, A BACTERIAL DISEASE WITH UNEXPECTED SURVIVAL RATES
Prof. ANDRÉ FONTAINE
Infectious disease veterinarian, specialist in infectious zoonoses
Leptospirosis: not just a tropical infection
Icterohemorrhagic leptospirosis is the predominant form of the disease in several countries worldwide, including, for example, France, its overseas departments (except Mayotte)(1), the United Kingdom(3), and the Netherlands(4).
This infection is endemic in tropical and subtropical regions, but can also be found in regions with more temperate climates. Globally, more and more people are contracting leptospirosis each year, with more than a million severe cases reported annually, including 60,000 fatalities(1).
Leptospirosis is re-emerging in Europe and across the globe(7). It is an overlooked, and very probably underestimated, disease(1).
In the United Kingdom, for example, 2017 saw the highest incidence for 10 years(8,9).
In metropolitan France, the number of cases has doubled in recent years, rising from 300 to more than 600 identified cases annually, i.e. more than one case a day since 2014. In 2014, 628 cases of leptospirosis were identified in mainland France, the highest incidence for 80 years(10).
According to experts, leptospirosis is an emerging public health issue. Climate change and urbanization promotes the spread of this disease, particularly through the proliferation of rats and coypu in our cities and countryside(1).
Laboratory confirmed cases of leptospirosis in humans in the United Kingdom
Cases of leptospirosis identified in metropolitan France
Rights of workers exposed to leptospirosis
The potentially serious consequences of leptospirosis on the health of workers has led the International Labor Organization to recognize it as an occupational disease, in order to ensure that victims are compensated(11).
This recognition is also applicable under European law(12).The protection of workers is guaranteed under French law, for example: employers are obliged to protect the moral and physical health of their employees and agents, with the assistance of Occupational Physicians and Multidisciplinary Occupational Health Teams(13,14).
Leptospirosis affects several professions. In France, leptospirosis is sometimes commonly known as “sewage worker’s disease” (maladie des égoutiers),
as these workers are directly exposed to rats and to water contaminated with their urine. However, this is not the only job that carries a risk of leptospirosis infection. In France, for example, tables of occupational diseases suggest a list of at-risk activities that fall under the following definition: “work that exposes staff to contact with animals likely to be carrying bacteria, particularly when performed in contact with water or in humid places likely to be contaminated with the excrement of such animals.” In France, leptospirosis is work-related in a third of all identified cases. Among working-age individuals, 54% of cases are contracted at work(15,16).
In the United Kingdom, the Health and Safety Executive (HSE), which has responsibility over occupational health and safety, lists some professions carrying the risk of leptospirosis (Weil’s disease): watersports instructors; workers in outdoor leisure industries, particularly if in contact with water; sewage and waste water workers; construction/demolition/building renovation workers – where there are rodents or stagnant water; farm workers; and pest control workers(17).
Rodents and fresh water: the primary risk factors.
Once dispersed through the urine of contaminated animals, such as rats or livestock, the bacteria which cause leptospirosis can survive for up to six months in fresh water or a humid location(18, 19). If you know someone who is at risk of contracting leptospirosis due to the nature of their work (sanitation, public works, etc.) or leisure activities (canyoning, triathlon, fishing, hunting, etc.), it’s essential that they take measures to protect themselves, as Leptospira are thin, mobile bacteria that can penetrate the body through various means(20).
These bacteria can penetrate through:
– wounds or scratches
– eyes, nose, mouth
– the dilated pores of healthy macerated skin(20)
A potentially serious illness.
The first symptoms of leptospirosis may present rapidly after contact with the bacteria, or sometimes over a longer timeframe – which can make diagnosis slow and difficult(20).
If initiated early, antibiotic treatment can suffice to treat leptospirosis, but in some cases the infection can continue to worsen.
In the most serious cases, the Leptospira can damage organs such as the kidneys, liver, and lungs, and admission to an intensive care unit is thus often necessary. Leptospirosis can still sometimes be fatal, even when intensive care measures have been taken(20).
When dealing with leptospirosis,
prevention is better than a cure.
As leptospirosis is a misunderstood illness, awareness among those who perform at-risk activities is a necessity.
In case of regular exposure
You should use and recommend appropriate methods of prevention.
Healthcare professionals can answer questions and advise on actions and appropriate means of protection for professional or leisure activities (wearing boots, goggles, etc.)(21,22).
Healthcare professionals can also assess whether vaccination is necessary, in addition to the other methods of prevention, based on the official recommendations.
Disinfect and protect
wounds or scratches with waterproof dressing
Wash your hands
with soap and clean water after sport or leisure activities
Avoid any contact
with your eyes, nose and mouth with dirty hands
Wear protective equipment
depending on the activity (boots, overalls, protective goggles)
Consult your general practitioner
if you experience influenza-like symptoms and inform those exposed
if advised to do so by a healthcare professional, based on official recommendations.
The bacteria that causes leptospirosis is a Group 2 biological agent, i.e. one which “Can cause human disease and may be a hazard to employees; it is unlikely to spread to the community and there is usually effective prophylaxis or treatment available” (23).
In France, specific monitoring of group 2 biological agents – such as leptospirosis – should be performed jointly by the between the employer and the Department of Occupational Health(14). This monitoring allows an effective and appropriate prevention plan to be put in place.
The Health and Safety Executive (HSE) in the United Kingdom has developed an “Are you at risk?” information sheet for at-risk workers(24).
It is also important to limit the proliferation of rodents and rats, particularly through good waste management practices.
IMAXIO engages with occupational healthcare professionals and health authorities to prevent and to increase awareness about leptospirosis risks at work with different tools.
Discover our page dedicated to leptospirosis.
Access our Facebook page
(1) Filleul L. et al. ; Santé Publique France – La leptospirose dans les régions et départements français d’outre-mer; Bulletin Epidémiologique Hebdomadaire ; 4 avril 2017 ; numéro 8-9
(2) Estavoyer JM. , « Leptospirose en Franche-Comté : données cliniques, biologiques et thérapeutiques. Médecine et maladies infectieuses »; Septembre 2013: pages 379-385
(3) A.E. FORBES, W.J. ZOCHOWSKI, S.W. DUBREY and V. SIVAPRAKASAM. Leptospirosis and Weil’s disease in the UK. QJM. 2012 ; 105 : 1151-1162
(4) Goris, M.G.A. (2016, April 6). Leptospirosis: epidemiology, clinical aspects and diagnosis. Erasmus University Rotterdam. Retrieved from http://hdl.handle.net/1765/80097
(5) Rapport d’activité 2013 pour l’année 2012 du Centre National de Référence de la Leptospirose – Inst. Pasteur Paris
(6) Berry AL et al. Bilan de la surveillance de la leptospirose en Polynésie Française 2006-2012 Bull. Info. Sanit. Epidémio. Stat. Dir. de la santé de Polynésie Fr. 2013; 9: 4-6.
(7) Dupouey J et al. Human leptospirosis : an emerging risk in Europe? Comparative Immunology, Microbiology and Infectious Diseases 37 (2014) 77– 83
(8) Public Health England. Zoonoses Overview Report UK 2016. HM Government ; 2017. 50. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/664448/UK_Zoonoses_report_2016.pdf
(9) Public Health England. Common animal associated infections quarterly report (England and Wales) : fourth quarter 2017. Health Protection Report. Volume 12 Number 5. 9 february 2018. 7. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/680710/hpr0518_zoos.pdf
(10) Picardeau M., Rapport annuel d’activité du CNRL 2018 pour l’année d’exercice 2017.
(11) International Labour Office, List of occupational diseases (revised 2010). Geneva 2010 ; N°74 : 0-72.
(12) Directive Européenne 2000/54/CE (JOCE L. 262 du 17/10/2000)
(13) Soc. 30.11.2010 n°08-70.39
(14) Article L4622-2 du Code du Travail modifié par la loi n°2015-994 du 17 août 2015 – art. 16
(15) Baranton G, Postic D Centre National de Référence des leptospires, Institut Pasteur Paris, Synthèse La leptospirose en France de 2001 à 2003 : 1-8
(16) Watrin M. Étude descriptive des cas de leptospirose diagnostiqués en Normandie sur la période 2010-2014. Saint-Maurice : Institut de veille sanitaire ; 2016: 1-28.
(17) Health and Safety Executive. Leptospirosis (Weil‘s disease and Hardjo). 3. http://www.hse.gov.uk/agriculture/zoonoses-data-sheets/leptospirosis.pdf
(18) Ferguson IR. A european Perspective on Leptospirosis. Microbiology Europe 1994; janv-fév: 8-11
(19) Andre-Fontaine G et al. Waterborne Leptospirosis: Survival and Preservation of the Virulence of Pathogenic Leptospira spp. In Fresh Water. Curr Microbiol. 2015 Jul;71(1):136-42
(20) Adler B. (Ed) Leptospira and Leptospirosis, Current Topics in Microbiology and Immunology Sringer-Verlag Berlin Heidelberg 2015; 387: 1-293. DOI 10.1007/978-3-662-45059-8.
(21) Avis du Conseil Supérieur d’Hygiène Publique en France relatif aux recommandations pour la prévention de la leptospirose dans la population générale (séance du 30 septembre 2005)
(22) Avis du Conseil Supérieur d’Hygiène Publique en France relatif aux recommandations pour la prévention de la leptospirose en cas d’activité professionnelle à risque (séance du 18 mars 2005)
(23) Health and Safety Executive. The Approved List of Biological Agent. Advisory Committee on Dangerous Pathogens; Third Edition 2013. 35. http://www.hse.gov.uk/pUbns/misc208.pdf
(24) Health and Safety Executive. Leptospirosis Are you at Risk ? 2011. 2.https://www1.essex.ac.uk/health-safety/substances/documents/hse-guidance-leptospirosis.pdf
Last Updated : 21 november 2019